Tyrosine Kinase


Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
-
A3145 Afatinib dimaleateTarget: EGFR|HER2Summary: EGFR inhibitor -
A3148 AIM-100Summary: Ack1 inhibitor -
A3155 ALK inhibitor 2Summary: ALK inhibitor, novel and selective -
A3165 ALW-II-41-271 CitationTarget: Eph ReceptorsSummary: Eph receptor inhibitor -
A3193 ASP3026Summary: ALK inhibitor,potent and selective -
A3194 AST 4871 CitationTarget: RETSummary: RET kinase inhibitor -
A3209 AXL1717Target: Insulin-like growth factor receptors(IGFRs)Summary: IGF-1R inhibitor,orally active -
A3227 BAY 61-3606Target: SykSummary: Syk Inhibitor -
A3228 BAY 61-3606 dihydrochlorideSummary: Syk tyrosine kinase inhibitor -
A3240 BIBX 1382Summary: EGFR inhibitor,potent and selective

